GB201615588D0 - TSLP Binding Proteins - Google Patents

TSLP Binding Proteins

Info

Publication number: GB201615588D0
Authority: GB; United Kingdom
Prior art keywords: binding proteins; tslp binding; tslp; proteins; binding
Prior art date: 2016-09-14
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Ceased

Application number

GBGB1615588.9A

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

GlaxoSmithKline Intellectual Property Development Ltd

Original Assignee

GlaxoSmithKline Intellectual Property Development Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2016-09-14

Filing date

2016-09-14

Publication date

2016-10-26

2016-09-14 Application filed by GlaxoSmithKline Intellectual Property Development Ltd filed Critical GlaxoSmithKline Intellectual Property Development Ltd

2016-09-14 Priority to GBGB1615588.9A priority Critical patent/GB201615588D0/en

2016-10-26 Publication of GB201615588D0 publication Critical patent/GB201615588D0/en

2017-03-07 Priority to PCT/EP2017/055356 priority patent/WO2017153426A1/en

Status Ceased legal-status Critical Current

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/24—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
- C07K16/244—Interleukins [IL]
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
- C07K2317/21—Immunoglobulins specific features characterized by taxonomic origin from primates, e.g. man
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/30—Immunoglobulins specific features characterized by aspects of specificity or valency
- C07K2317/33—Crossreactivity, e.g. for species or epitope, or lack of said crossreactivity
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/30—Immunoglobulins specific features characterized by aspects of specificity or valency
- C07K2317/34—Identification of a linear epitope shorter than 20 amino acid residues or of a conformational epitope defined by amino acid residues
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
- C07K2317/56—Immunoglobulins specific features characterized by immunoglobulin fragments variable (Fv) region, i.e. VH and/or VL
- C07K2317/565—Complementarity determining region [CDR]
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
- C07K2317/56—Immunoglobulins specific features characterized by immunoglobulin fragments variable (Fv) region, i.e. VH and/or VL
- C07K2317/567—Framework region [FR]
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
- C07K2317/56—Immunoglobulins specific features characterized by immunoglobulin fragments variable (Fv) region, i.e. VH and/or VL
- C07K2317/569—Single domain, e.g. dAb, sdAb, VHH, VNAR or nanobody®
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/70—Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/70—Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
- C07K2317/76—Antagonist effect on antigen, e.g. neutralization or inhibition of binding
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/90—Immunoglobulins specific features characterized by (pharmaco)kinetic aspects or by stability of the immunoglobulin
- C07K2317/92—Affinity (KD), association rate (Ka), dissociation rate (Kd) or EC50 value

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
General Health & Medical Sciences (AREA)
Biochemistry (AREA)
Biophysics (AREA)
Life Sciences & Earth Sciences (AREA)
Genetics & Genomics (AREA)
Medicinal Chemistry (AREA)
Molecular Biology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Immunology (AREA)
Peptides Or Proteins (AREA)

GBGB1615588.9A 2016-03-09 2016-09-14 TSLP Binding Proteins Ceased GB201615588D0 (en)

Priority Applications (2)

Application Number	Priority Date	Filing Date	Title
GBGB1615588.9A GB201615588D0 (en)	2016-09-14	2016-09-14	TSLP Binding Proteins
PCT/EP2017/055356 WO2017153426A1 (en)	2016-03-09	2017-03-07	Tslp binding proteins

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
GBGB1615588.9A GB201615588D0 (en)	2016-09-14	2016-09-14	TSLP Binding Proteins

Publications (1)

Publication Number	Publication Date
GB201615588D0 true GB201615588D0 (en)	2016-10-26

Family

ID=57234758

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
GBGB1615588.9A Ceased GB201615588D0 (en)	2016-03-09	2016-09-14	TSLP Binding Proteins

Country Status (2)

Country	Link
GB (1)	GB201615588D0 (en)
WO (1)	WO2017153426A1 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CN114853888B (en) *	2021-02-05	2023-11-03	上海洛启生物医药技术有限公司	anti-TSLP nanobody and application thereof
CN117209604B (en) *	2021-12-02	2024-03-22	北京东方百泰生物科技股份有限公司	An anti-TSLP monoclonal antibody, its antigen-binding fragment and its application
WO2024152881A1 (en) *	2023-01-19	2024-07-25	甘李药业股份有限公司	Anti-tslp antibody and use thereof
CN117964755B (en) *	2023-12-26	2025-01-21	华润生物医药有限公司	Anti-TSLP antibodies and uses thereof

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
ATE416190T1 (en)	2003-07-04	2008-12-15	Affibody Ab	POLYPEPTIDES WITH BINDING AFFINITY FOR HER2
GB0603683D0 (en) *	2006-02-23	2006-04-05	Novartis Ag	Organic compounds
WO2008076321A1 (en) *	2006-12-14	2008-06-26	Schering Corporation	Engineered anti-tslp antibody
US7982016B2 (en) *	2007-09-10	2011-07-19	Amgen Inc.	Antigen binding proteins capable of binding thymic stromal lymphopoietin
GB201305668D0 (en)	2013-03-28	2013-05-15	Glaxosmithkline Ip Dev Ltd	Avs6 Integrin Antagonists
JP2016522165A (en) *	2013-04-04	2016-07-28	イエオ−イスティトゥート・エウロペオ・ディ・オンコロジア・エッセ・エッレ・エッレ	Thymic stromal lymphocyte neogenesis factor fragment and use thereof

2016
- 2016-09-14 GB GBGB1615588.9A patent/GB201615588D0/en not_active Ceased
2017
- 2017-03-07 WO PCT/EP2017/055356 patent/WO2017153426A1/en not_active Ceased

Also Published As

Publication number	Publication date
WO2017153426A1 (en)	2017-09-14

Publication	Publication Date	Title
IL275510A (en)	2020-08-31	Ror1-specific antigen binding molecules
ZA201808160B (en)	2021-08-25	Bispecific binding proteins and uses thereof
IL272064A (en)	2020-03-31	Binding proteins 1
SG10202107880XA (en)	2021-09-29	Mesothelin binding proteins
ZA201804317B (en)	2019-09-25	Altered april binding antibodies
ZA201802440B (en)	2023-05-31	Cd3 binding polypeptides
IL266800A (en)	2019-08-29	Prostate specific membrane antigen binding protein
IL274926A (en)	2020-07-30	Engineered dna binding proteins
EP3324996A4 (en)	2019-04-17	Gdf11 binding proteins and uses thereof
EP3247724B8 (en)	2025-04-16	Il-17a binding proteins
ZA201701912B (en)	2018-05-30	Antigen binding proteins that bind cxcr5
GB201418713D0 (en)	2014-12-03	Bindings Proteins
GB201608197D0 (en)	2016-06-22	Novel proteins
IL259519B (en)	2022-06-01	Cd131 binding proteins and uses thereof
ZA201901862B (en)	2020-09-30	Modified factor h binding protein
IL256298A (en)	2018-02-28	Multi-specific binding proteins
GB2558968B (en)	2021-09-29	G Proteins
GB201615588D0 (en)	2016-10-26	TSLP Binding Proteins
ZA201906821B (en)	2021-06-30	Anti-jagged1 antigen binding proteins
IL269477A (en)	2019-11-28	Il-1r-i binding polypeptide
IL267318A (en)	2019-08-29	Binding assay
GB201614627D0 (en)	2016-10-12	Antigen binding proteins
GB201703049D0 (en)	2017-04-12	Single-strand binding protein
IL266419A (en)	2019-06-30	Binding peptides
GB201715149D0 (en)	2017-11-01	IL-ß binding antibody

Legal Events

Date	Code	Title	Description
2018-03-14	AT	Applications terminated before publication under section 16(1)